Fundraising FoxMyosin Therapeutics
Jupiter, US · Founded 2020 · Delaware corporation · 6 known investors
Find your way into Myosin Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
Ask Sarah Hassan to introduce you to Courtney Miller
You →Sarah · together at Myosin Therapeutics Inc. →Courtney
Sign up to find every way you can get introduced to Myosin Therapeutics
- Your email: who you already know at Myosin Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Myosin Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
Myosin Therapeutics was founded in 2020 by Courtney Miller.
Investors · 6
How we know: biospace.com · Not right? Tell us
Also in the syndicate · 4
Funding
SEC filings, press & company announcements$6M disclosed across 2 rounds · 2022–2025
- $3MSecond Seed FundingMar 2025 · 2 sources
DeepWork Capital (lead), Florida Opportunity Fund (lead), Mint12 Pharma (lead), Dynagrow Capital, Mayo Clinic Ventures, The Sontag Innovation Fund
Source ↗
▶$3MraisedMar 2023 · 4 investors · PharmaceuticalsRule 506(b)
- Patrick Griffin, Ph.D.Director
- Dave AdamsDirector
- Andrew RitterDirector
- Courtney MillerExecutive Officer, Director
- Robert FinizioDirector
- Theodore KameneckaDirector
- Jackson StreeterDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Myosin Therapeutics.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2023 | $406.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $2.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $325.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded Myosin Therapeutics?
- Myosin Therapeutics was founded by Courtney Miller in 2020.
- Who are Myosin Therapeutics's investors?
- Myosin Therapeutics's investors include DeepWork Capital, Mayo Clinic Ventures.
- How much funding has Myosin Therapeutics raised?
- Myosin Therapeutics has disclosed $6M raised across 2 rounds.
- Where is Myosin Therapeutics headquartered?
- Myosin Therapeutics is headquartered in Jupiter, US.